Noida, India

Khushwant Singh

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jubilant Generics Limited. Active years: 2018.


% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Khushwant Singh: Innovator in Pharmaceutical Processes

Introduction

Khushwant Singh is a notable inventor based in Noida, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. His work is characterized by a focus on improving existing methodologies to enhance efficiency and effectiveness.

Latest Patents

Khushwant Singh holds a patent for a process related to the preparation of apixaban and its intermediates. The patent, titled "Process for the preparation of apixaban and intermediates thereof," outlines an improved method for synthesizing apixaban, a medication used to prevent blood clots. This invention also introduces novel intermediates, contributing to advancements in pharmaceutical manufacturing.

Career Highlights

Currently, Khushwant Singh is associated with Jubilant Generics Limited, a company known for its commitment to innovation in the pharmaceutical sector. His role involves leveraging his expertise to develop new processes that can lead to more effective drug formulations.

Collaborations

Throughout his career, Khushwant Singh has collaborated with several professionals in the industry, including Jai Prakash Verma and Rajendra Shekhawat. These collaborations have fostered a productive environment for innovation and have contributed to the success of various projects.

Conclusion

Khushwant Singh's contributions to the pharmaceutical industry through his innovative processes exemplify the impact of dedicated inventors in advancing healthcare solutions. His work continues to influence the field, paving the way for future developments in drug preparation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…